This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2006 Jun;26(6):886-7; discussion 887.

doi: 10.1592/phco.26.6.886.

Reduction of high-risk polypharmacy drug combinations in patients in a managed care setting

David S Craig¹

Affiliations

Affiliation

¹ Psychosocial, Palliative Care and Integrative Medicine Department, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida 33612, USA. craigds@moffitt.usf.edu

PMID: 16716143
DOI: 10.1592/phco.26.6.886

Comment

Reduction of high-risk polypharmacy drug combinations in patients in a managed care setting

David S Craig. Pharmacotherapy. 2006 Jun.

. 2006 Jun;26(6):886-7; discussion 887.

doi: 10.1592/phco.26.6.886.

Author

David S Craig¹

Affiliation

¹ Psychosocial, Palliative Care and Integrative Medicine Department, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida 33612, USA. craigds@moffitt.usf.edu

PMID: 16716143
DOI: 10.1592/phco.26.6.886

No abstract available

PubMed Disclaimer

Comment on

Reduction of high-risk polypharmacy drug combinations in patients in a managed care setting.
Zarowitz BJ, Stebelsky LA, Muma BK, Romain TM, Peterson EL. Zarowitz BJ, et al. Pharmacotherapy. 2005 Nov;25(11):1636-45. doi: 10.1592/phco.2005.25.11.1636. Pharmacotherapy. 2005. PMID: 16232025

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley
Medical
- MedlinePlus Health Information